Stockreport

Ionis presents positive results from Phase 3 Balance study of olezarsen for familial chylomicronemia syndrome

Ionis Pharmaceuticals, Inc.  (IONS) 
Last ionis pharmaceuticals, inc. earnings: 2/26 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: ionispharma.com